Joan W. Miller
Joan W. Miller
Professor of Ophthalmology, Harvard Medical School
Verified email at meei.harvard.edu
Title
Cited by
Cited by
Year
Age-related macular degeneration
RD Jager, WF Mieler, JW Miller
New England Journal of Medicine 358 (24), 2606-2617, 2008
16232008
Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials-TAP report 1
Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP ...
Arch ophthalmol 117, 1329-1345, 1999
16171999
Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy
AP Adamis, JW Miller, MT Bernal, DJ D'Amico, J Folkman, TK Yeo, ...
American journal of ophthalmology 118 (4), 445-450, 1994
15451994
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult …
VIPTS Group1A
American journal of ophthalmology 131 (5), 541-560, 2001
9172001
Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model
JW Miller, AP Adamis, DT Shima, PA D'Amore, RS Moulton, MS O'Reilly, ...
The American journal of pathology 145 (3), 574, 1994
8811994
Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.
NM Bressler
Archives of ophthalmology (Chicago, Ill.: 1960) 119 (2), 198-207, 2001
8182001
Inhibition of vascular endothelial growth factor prevents retinal ischemia—associated iris neovascularization in a nonhuman primate
AP Adamis, DT Shima, MJ Tolentino, ES Gragoudas, N Ferrara, ...
Archives of ophthalmology 114 (1), 66-71, 1996
7631996
Prevention of experimental choroidal neovascularization with intravitreal anti–vascular endothelial growth factor antibody fragment
MG Krzystolik, MA Afshari, AP Adamis, J Gaudreault, ES Gragoudas, ...
Archives of ophthalmology 120 (3), 338-346, 2002
7212002
Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate
MJ Tolentino, JW Miller, ES Gragoudas, FA Jakobiec, E Flynn, ...
Ophthalmology 103 (11), 1820-1828, 1996
6221996
Principles and practice of ophthalmology
DM Albert, FA Jakobiec
WB Saunders company, 2000
5972000
VEGF164-mediated Inflammation Is Required for Pathological, but Not Physiological, Ischemia-induced Retinal Neovascularization
S Ishida, T Usui, K Yamashiro, Y Kaji, S Amano, Y Ogura, T Hida, ...
The Journal of experimental medicine 198 (3), 483-489, 2003
5332003
Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration
W Chen, D Stambolian, AO Edwards, KE Branham, M Othman, ...
Proceedings of the National Academy of Sciences 107 (16), 7401-7406, 2010
5112010
Diffusion of high molecular weight compounds through sclera
J Ambati, CS Canakis, JW Miller, ES Gragoudas, A Edwards, ...
Investigative ophthalmology & visual science 41 (5), 1181-1185, 2000
4612000
Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study
JW Miller, U Schmidt-Erfurth, M Sickenberg, CJ Pournaras, H Laqua, ...
Archives of ophthalmology 117 (9), 1161-1173, 1999
4321999
Tumor necrosis factor-α mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma
T Nakazawa, C Nakazawa, A Matsubara, K Noda, T Hisatomi, H She, ...
Journal of Neuroscience 26 (49), 12633-12641, 2006
4052006
Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study
U Schmidt-Erfurth, JW Miller, M Sickenberg, H Laqua, I Barbazetto, ...
Archives of Ophthalmology 117 (9), 1177-1187, 1999
3991999
Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate
MJ Tolentino, JW Miller, ES Gragoudas, K Chatzistefanou, N Ferrara, ...
Archives of Ophthalmology 114 (8), 964-970, 1996
3991996
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.
KJ Blinder, MS Blumenkranz, NM Bressler, SB Bressler, G Donato, ...
Ophthalmology 110 (4), 667-673, 2003
3722003
Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy
JW Miller, AP Adamis, LP Aiello
Diabetes/metabolism reviews 13 (1), 37-50, 1997
3511997
Vascular endothelial growth factor a in intraocular vascular disease
JW Miller, J Le Couter, EC Strauss, N Ferrara
Ophthalmology 120 (1), 106-114, 2013
3352013
The system can't perform the operation now. Try again later.
Articles 1–20